Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae

Infection and Immunity

Volumn 79, Issue 10, 2011, Pages 4210-4217

  Olliver, Marie ^a   Hiew, Jeffni ^a   Mellroth, Peter ^a   Henriques Normark, Birgitta ^a,b   Bergman, Peter ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIABILITY; CD4+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EFFECTOR CELL; HELPER CELL; MEMORY T LYMPHOCYTE; MONOCYTE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TH1 CELL; TH17 CELL; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-17; MONOCYTES; PEPTIDOGLYCAN; STREPTOCOCCUS PNEUMONIAE; TH1 CELLS; TH17 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 80855164771     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05286-11     Document Type: Article

References (46)

1. Duraisingham, S. S., J. Hornig, F. Gotch, and S. Patterson. 2009. TLRstimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J. Immunol. 183:2242-2251.
2. Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73:5212-5216.
3. Echchannaoui, H., et al. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186:798-806.
4. Evans, H. G., T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. U. S. A. 104:17034-17039.
5. Fernebro, J., et al. 2004. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance. J. Infect. Dis. 189:328-338.
6. Fritz, J. H., et al. 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26:445-459.
7. Granat, S. M., et al. 2009. Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. J. Infect. Dis. 200:99-106.
8. HenriqusNormark, B., et al. 2003. Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb. Drug Resist. 9:337-344.
9. Hoeve, M. A., et al. 2006. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36:661-670.
10. Kemp, K., H. Bruunsgaard, P. Skinhoj, and B. Klarlund Pedersen. 2002. Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect. Immun. 70:5019-5025.
11. Klein, M., et al. 2008. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J. Infect. Dis. 198:1028-1036.
12. Lee, J., et al. 2009. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 284:23818-23829.
13. Lin, Y., S. R. Slight, and S. A. Khader. 2010. Th17 cytokines and vaccineinduced immunity. Semin. Immunopathol. 32:79-90.
14. Lipsitch, M., et al. 2005. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med. 2:e15.
15. Littmann, M., et al. 2009. Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol. Med. 1:211-222.
16. Liu, H., and C. Rohowsky-Kochan. 2008. Regulation of IL-17 in human CCR6+ effector memory T cells. J. Immunol. 180:7948-7957.
17. Lord, F. T., and R. Heffron. 1938. Pneumonia and serum therapy. In H. Milford (ed.), Lobar pneumonia and serum therapy, revised ed. Oxford University Press, New York, NY.
18. Lu, Y. J., et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4:e1000159.
19. Malley, R., et al. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. U. S. A. 102:4848-4853.
20. McCool, T. L., and J. N. Weiser. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72:5807-5813.
21. McNeela, E. A., et al. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6:e1001191.
22. Millar, E. V., et al. 2007. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin. Infect. Dis. 44:1173-1179.
23. Milner, J. D., et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-776.
24. Mogensen, T. H., S. R. Paludan, M. Kilian, and L. Ostergaard. 2006. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol. 80:267-277.
25. Mureithi, M. W., et al. 2009. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J. Infect. Dis. 200:783-793.
26. Nakae, S., Y. Iwakura, H. Suto, and S. J. Galli. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81:1258-1268.
27. Nakamatsu, M., et al. 2007. Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect. 9:364-374.
28. Ochs, H. D., C. I. E. Smith, and J. Puck. 2007. Primary immunodeficiency diseases: a molecular and genetic approach, 2nd ed. Oxford University Press, New York, NY.
29. Opitz, B., et al. 2004. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279:36426-36432.
30. Rijneveld, A. W., et al. 2002. The role of interferon-gamma in murine pneumococcal pneumonia. J. Infect. Dis. 185:91-97.
31. Rosenthal, R. S., and R. Dziarski. 1994. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 235:253-285.
32. Rubins, J. B., and C. Pomeroy. 1997. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect. Immun. 65:2975-2977.
33. Schröder, N. W., et al. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278:15587-15594.
34. Sun, K., and D. W. Metzger. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 14:558-564.
35. Sun, K., S. L. Salmon, S. A. Lotz, and D. W. Metzger. 2007. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75:1196-1202.
36. Tettelin, H., et al. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506.
37. Travassos, L. H., et al. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5:1000-1006.
38. Trzcinski, K., C. Thompson, R. Malley, and M. Lipsitch. 2005. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect. Immun. 73:7043-7046.
39. van Beelen, A. J., et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660-669.
40. van de Veerdonk, F. L., et al. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5:329-340.
41. Volz, T., et al. 2010. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J. 24:4089-4102.
42. Weinberger, D. M., et al. 2008. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J. Infect. Dis. 197:1511-1518.
43. Wkly. Epidemiol. Rec. 2007. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly. Epidemiol. Rec. 82:93-104.
44. Yamamoto, N., et al. 2004. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma. Microbes Infect. 6:1241-1249.
45. Zemlicková, H., et al. 2006. Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus isolated from the nasopharynx of healthy children attending day-care centres in the Czech Republic. Epidemiol. Infect. 134:1179-1187.
46. Zhang, Z., T. B. Clarke, and J. N. Weiser. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest. 119:1899-1909.